BN Business News
Add your company to Business Communicator →

Business · 05/11/20261 min read

Telix joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeted Theranostics

Summary

Thera4Care is an initiative aimed at establishing an integrated theranostics ecosystem to broaden patient access in Europe Telix's fibroblast activation protein (FAP) targeting therapy candidate (TLX400-Tx) has been...

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →